This Lyell Immunopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Lyell Immunopharma, Inc.
Immuneering Corp. Class A
Atrium Therapeutics

Lyell Immunopharma, Inc.

LYEL

0.00

Immuneering Corp. Class A

IMRX

0.00

Atrium Therapeutics

RNA

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Stifel analyst Stephen Willey initiated coverage on Lyell Immunopharma Inc (NASDAQ:LYEL) with a Buy rating and announced a price target of $36. Lyell Immunopharma closed at $13.45 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Andres Y. Maldonado initiated coverage on Immuneering Corp (NASDAQ:IMRX) with a Buy rating and announced a price target of $14. Immuneering shares closed at $4.39 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Atrium Therapeutics Inc (NASDAQ:RNA) with a Buy rating and announced a price target of $25. Atrium Therapeutics closed at $11.74 on Wednesday. See how other analysts view this stock.

Considering buying LYEL stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.